XL-184+Abiraterone in Post-Chemo CRPC

Clinical trial NCT01574937 · COMPLETED

Trial details

NCT number: NCT01574937
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2012-04-03
Primary completion: 2014-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.